Sleep Apnea Devices Market, By Diagnostic Devices (Polysomnography Devices, Pulse Oximeters, and Actigraphy Devices), By Therapeutic Devices (Positive Airway Pressure (PAP) Devices, (Continuous Positive Airway Pressure (CPAP) Devices, and Bi-Level Positive Airway Pressure (BiPAP) Devices), Oxygen Devices (Oxygen Concentrators, Portable Oxygen Concentrators, and Liquid Portable Oxygen), Oral Appliances, Adaptive Servo Ventilation (ASV) Devices, and Masks and Accessories), By End User (Sleep Laboratories and Hospitals, and Home Care Settings/Individuals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast Till 2034

Sleep Apnea Devices Market was valued at US$ 6.2 Billion in 2024 and is projected to grow at a CAGR of 6.70% to reach US$ 11.8 Billion by 2034.

Apnea occurs when the body and brain receive insufficient oxygen and breathing process is interrupted during sleep. OSA is the most common form of apnea caused by airway blockage. In order to avoid this, it is necessary for patients to undergo diagnostic tests and use therapeutic treatment devices. OSA is widely prevalent in the elderly population, patients suffering from cardiovascular diseases, and other non-communicable diseases such as diabetes, hypertension, and remains underdiagnosed owing to lack of awareness, poor healthcare infrastructure in developing countries, and non-specific presentation of the disease. There are different types of treatment options are available to recover sleep apnea. For example, wear an oral device, surgery for sleep apnea, undergoing a weight management, positional therapy and behaviors therapy. Additionally, Hypoglossal Nerve Stimulation, Expiratory Positive Airway Pressure, Positive Airway Pressure Therapy, Oral Pressure Therapy these are some latest therapy which is used in sleep apnea.

                   For More Report Details, Download Free Sample PDF

Sleep apnea devices market is segmented based on diagnostic devices, therapeutic devices, end user and region.

On the basis of diagnostic devices, the sleep apnea devices market is segmented into polysomnography devices, pulse oximeters, and actigraphy devices. Based on therapeutic devices, the target market is classified into positive airway pressure (pap) devices, (continuous positive airway pressure (cPAP) devices, and bi-level positive airway pressure (biPAP) devices), oxygen devices (oxygen concentrators, portable oxygen concentrators, and liquid portable oxygen), oral appliances, adaptive servo ventilation (asv) devices, and masks and accessories. Based on end user, the global market is characterized into sleep laboratories and hospitals, and home care settings/individuals.

 Regional Insights:

On region the sleep apnea devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America dominates the global market in terms of revenue and is projected to continue its dominance in the coming years. This region is expected to increase its market share in the future, owing to the high incidence of sleep-disordered breathing (SDB) and rising aging population in the region. Asia Pacific is projected to be the fastest growing market over the forecast period with a CAGR of 15.2% over the forecast period. Asia Pacific has the largest number of undiagnosed sleep apnea patients in the world. This presents a lucrative opportunity for the manufacturers.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the sleep apnea devices market report based on diagnostic devices, therapeutic devices, end user and region:

Sleep Apnea Devices Market, By Diagnostic Devices:

• Polysomnography Devices
• Pulse Oximeters
• Actigraphy Devices

Sleep Apnea Devices Market, By Therapeutic Devices:

• Positive Airway Pressure (PAP) Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Bi-Level Positive Airway Pressure (BiPAP) Devices
• Oxygen Devices
  • Oxygen Concentrators
  • Portable Oxygen Concentrators
  • Liquid Portable Oxygen
• Oral Appliances
• Adaptive Servo Ventilation (ASV) Devices
• Masks and Accessories

Sleep Apnea Devices Market, By End User:

• Sleep Laboratories and Hospitals
• Home Care Settings/Individuals

Sleep Apnea Devices Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating the Sleep Apnea Devices market includes GE Healthcare, Fisher & Paykel Healthcare Limited, BMC Medical Co. Ltd, Cadwell Laboratories ResMed, Invacare Corporation, Braebon Medical Corporation, ImThera Medical Inc., Phillips Respironics, Curative Medical Inc., and Nihon Kohden. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

For instance, in August 2019, American Thoracic Society announced that Oral appliances may be highly effective in treating a type of sleep apnea. In April 2019, Hiroshima University Researchers measured a novel treatment for sleep apnea and found positive results. By measuring patients lying down flat, the researchers stimulated sleep conditions and measured the patient's airways using 3D imaging. The study confirmed that the treatment is effective at opening the airways and warrants further collaboration between dentists and doctors in treatment of sleep apnea.

• GE Healthcare
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
• Fisher & Paykel Healthcare Limited
• BMC Medical Co. Ltd
• Cadwell Laboratories ResMed
• Invacare Corporation
• Braebon Medical Corporation
• ImThera Medical Inc.
• Phillips Respironics
• Curative Medical Inc.
• Nihon Kohden

 “*” marked represents similar segmentation in other categories in the respective section